@slashgear.com 3 years ago
Popular thyroid drug recalled because it’s ‘super potent’ says FDA
@slashgear.com 4 years ago
High blood pressure drug recall expands again over cancer risk
@xconomy.com 5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com 5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com 5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@theverge.com 6 years ago
Cheaper alternative to EpiPen allergy shot approved by FDA